Patent details

EP1002795 Title: HIV Replication inhibiting pyrimidines

Basic Information

Publication number:
EP1002795
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Expired
Application number:
EP992035907
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
HIV Replication inhibiting pyrimidines
French Title of Invention:
Pyrimidines comme inhibiteurs de reproduction du VIH
German Title of Invention:
Pyrimidineihibitoren der HIV-Replikation
SPC Number:
91528

Dates

Filing date:
01/11/1999
Grant date:
05/03/2003
EP Publication Date:
05/03/2003
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
24/05/2000
EP B1 Publication Date:
05/03/2003
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
01/11/2019
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
01/11/1999
 
 

Name:
JANSSEN PHARMACEUTICA N.V.
Address:
Turnhoutseweg 30, 2340 Beerse, Belgium (BE)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
10/04/2003
Address:
PO Box 48, 8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
De Corte Bart
Address:
United States (US)

2

Name:
Van Aken Koen Jeanne Alfons
Address:
Belgium (BE)

3

Name:
Ludovici Donald William
Address:
United States (US)

4

Name:
Andries Koenraad Jozef Lodewijk Marcel
Address:
Belgium (BE)

5

Name:
Janssen Paul Adriaan Jan
Address:
Belgium (BE)

6

Name:
De Jonge Marc René
Address:
Netherlands (NL)

7

Name:
Koymans Lucien Maria Henricus
Address:
Belgium (BE)

8

Name:
Ho Chih Yung
Address:
United States (US)

9

Name:
Kukla Michael Joseph
Address:
United States (US)

10

Name:
Heeres Jan
Address:
Belgium (BE)

11

Name:
Kavash Robert W.
Address:
United States (US)

Priority

1

Priority Number:
107792 P
Priority Date:
10/11/1998
Priority Country:
United States (US)

2

Priority Number:
143962 P
Priority Date:
15/07/1999
Priority Country:
United States (US)

3

Priority Number:
07417
Priority Date:
24/09/1999
Priority Country:
European Patent Office (EPO) (EP)

Classification

Main IPC Class:
C07D 239/48;

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
24/10/2018
Last Annual Fee Paid Number:
20
Last Annual Fee Paid Amount:
300 Euro
Payer:
MARKS & CLERK LLP
Filing date Document type Number of pages